Navigation Links
Cardica Announces Fiscal 2010 Second Quarter Financial Results
Date:1/28/2010

REDWOOD CITY, Calif., Jan. 28 /PRNewswire-FirstCall/ -- Cardica, Inc. (Nasdaq: CRDC) today announced financial results for its fiscal second quarter and six months ended December 31, 2009. Cardica's management will host a conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide an update on the company's business.

"This quarter, as we continued to transition the sales model for our cardiac anastomosis products from a direct sales force to a team driven largely by independent distributors and manufacturers' representatives, we saw sequential growth in sales of our automated anastomosis products, which is a trend that we expect to continue moving forward," said Bernard A. Hausen, M.D., Ph.D., president and chief executive officer of Cardica.

"We are advancing development of our Cardica Microcutter ES8, the first potential product in our anticipated line of endolinear stapler/cutters, and we expect to initiate testing in animals during our fiscal third quarter.  Subject to FDA clearance under a 510(k) process, we anticipate launching this product in the United States in early calendar 2011. We believe the opportunity to apply our proprietary technology and development capabilities to this $2 billion market could provide the company with exceptional growth opportunities in the years ahead," continued Dr. Hausen.

Recent Highlights and Accomplishments

  • Increased cumulative worldwide shipments of PAS-Port® Proximal Anastomosis Systems to over 17,000 units, with 1,120 units shipped in the fiscal
    '/>"/>

SOURCE Cardica, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Cardica Announces Fiscal 2010 First Quarter Financial Results and Business Progress
2. Cardica Announces Publication of Pivotal PAS-Port(R) Proximal Anastomosis System Clinical Trial Results
3. Cardica to Host Investor Briefing on Revolutionizing Revascularization
4. Cardica Reports Positive Top-Line Results and Submits 510(k) for PAS-Port(R) Proximal Anastomosis System in Cardiac Bypass Surgery
5. Sequenom Announces Addition to Clinical Advisory Board
6. Omnicell Announces Fourth Quarter and Full-Year 2009 Results
7. Life Spine(R) Announces FDA Clearance of DYNA-LINK(R) Spinal System and PRESIDIO(TM) Spinal Plating System
8. Repligen Announces Long Term Supply Agreement with GE Healthcare for Recombinant Protein A
9. Omeros Announces National Institute on Drug Abuses Support for Phase 2 Clinical Study in Addiction Program
10. Sangamo BioSciences Announces Fourth Quarter and Full Year 2009 Conference Call and Webcast
11. CardioGenics Announces Completion of Cartridge Design for QL Care Analyzer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... , Sept. 18, 2014 This BCC Research report ... of major players, market growth and size, and opportunities for ... and revenue through 2018. Patent analysis in the report focuses ... the U.S., Europe and ... - Define and discuss the global medical device technologies market. ...
(Date:9/18/2014)... , Sept. 18, 2014  Iliad Neurosciences, Inc., a ... diagnosing and treating Autism Spectrum Disorders (ASD) announced today ... with The Research Foundation for The State University of ... provide a new biomarker to identify an abnormality in ... ASD. This biomarker is expected to be available for ...
(Date:9/18/2014)... Pharma IQ, after huge demand ... Countdown calendar to cover the years 2014 - 2018 ... shows the serialisation requirements around the globe and the ... For companies dealing with international markets, serialisation ... they will have to comply with new regulations coming ...
Breaking Medicine Technology:Medical Devices: Technologies and Global Markets 2Medical Devices: Technologies and Global Markets 3Medical Devices: Technologies and Global Markets 4Iliad Neurosciences, Inc. enters into an Exclusive License Agreement with The Research Foundation for The State University of New York 2Iliad Neurosciences, Inc. enters into an Exclusive License Agreement with The Research Foundation for The State University of New York 3Pharma IQ Displays Worldwide Serialisation Deadlines in their 2014 - 2018 Countdown Calendar 2
... Intellect Neurosciences, Inc. (OTCBB: ILNS), a biopharmaceutical company ... therapeutic agents for the treatment of Alzheimer,s and ... filed a response and request for continued examination ... 10/084,380, one of several applications pending in the ...
... VIEW, Calif., Nov. 3, 2011 VIVUS, Inc. (NASDAQ: ... chief financial officer, will present an overview of the ... The VIVUS presentation will take place at the ... at 9:30 a.m. MST.  A live webcast and 30-day ...
Cached Medicine Technology:Intellect Neurosciences Responds to Official Action by United States Patent and Trademark Office in Relation to its ANTISENILIN® Alzheimer's Patent Application 2Intellect Neurosciences Responds to Official Action by United States Patent and Trademark Office in Relation to its ANTISENILIN® Alzheimer's Patent Application 3
(Date:9/18/2014)... New York (PRWEB) September 18, 2014 ... report published by Transparency Market Research "Pipeline ... (Tedizolid Phosphate, Ceftolozane/Tazobactam, Ceftazidime/Avibactam, Amikacin Inhale, Plazomicin, ... Share, Growth, Trends and Forecast 2014 - ... total revenue of USD 3.8 billion by ...
(Date:9/18/2014)... MD (PRWEB) September 18, 2014 ... are pleased to announce the release of Activz ... the nutrient-rich liquid of young, organic coconuts from Thailand. ... the highly-acclaimed Activz Whole-Food Nutrition revolutionary line of produce ... and grass options. The new Activz Coconut Water ...
(Date:9/18/2014)... By Dennis Thompson ... -- There is little evidence that testosterone replacement therapy ... American males, a U.S. Food and Drug Administration advisory panel ... overwhelmingly voted, 20-1, to tighten use of the popular drugs ... risk of heart attack and stroke, according to Bloomberg ...
(Date:9/18/2014)... Individuals living in disadvantaged neighborhoods have worse musculoskeletal ... as motor vehicle collision than individuals from higher ... characteristics such as age, sex, income, education, and ... a multi-site research study led by Samuel McLean, ... medicine at the University of North Carolina School ...
(Date:9/18/2014)... 2014 CRDF Global released today ... digital edition – rich with videos, images and ... CRDF Global empowers scientists and innovators around the ... corporate, foundation and individual supporters, CRDF Global reaches ... research, training and entrepreneurship. , The Annual Report ...
Breaking Medicine News(10 mins):Health News:Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Reveals Six Potential Late Stage Candidates and Ten Late Stage Candidates: Transparency Market Research 2Health News:Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Reveals Six Potential Late Stage Candidates and Ten Late Stage Candidates: Transparency Market Research 3Health News:Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market Reveals Six Potential Late Stage Candidates and Ten Late Stage Candidates: Transparency Market Research 4Health News:New Activz Organic Coconut Water Powder Announced at Natural Products Expo East 2Health News:New Activz Organic Coconut Water Powder Announced at Natural Products Expo East 3Health News:FDA Panel: Limit Testosterone Drug Use 2Health News:FDA Panel: Limit Testosterone Drug Use 3Health News:FDA Panel: Limit Testosterone Drug Use 4Health News:Living in a disadvantaged neighborhood worsens musculoskeletal pain outcomes after trauma 2Health News:CRDF Global Launches Media-Rich Digital Edition of Annual Report, Tells Story of Empowering Scientists and Innovators around the World in 2013 2
... the Closet, Thrift Store, Non-profit,AHF Pharmacy, Offers HIV/AIDS Expertise, ... Grand Opening Event to Include Ribbon-Cutting Ceremony, Free ... February,2nd at 10:00 a.m., AIDS Healthcare Foundation (AHF) will ... grand opening event to include,a ribbon-cutting ceremony and free ...
... is enthused about Part D,s success, but critics say ... -- The three-year-old Medicare Part D drug program is ... costs for the program fall, U.S. health officials announced ... considerably lower than originally projections, enrollment continues to rise ...
... romiplostim (Nplate) show that it significantly improved platelet levels ... hematologic disorder that can cause uncontrolled bleeding. An ... the drug, which duplicates the action of a natural ... in the February 2 issue of The Lancet. ...
... NEW YORK, Jan. 31 QED International Associates, ... 20 underlying,indexes for the HealthShares(TM) Exchange-Traded Funds, today ... Monday February 4, 2008,BioMerieux Worldwide (Euronext: BIM) will ... European Medical Products and Devices Index., Companies ...
... Lead Sponsor in Karmanos Cancer Institute,s Annual Dinner, ... Barbara Ann Karmanos,Cancer Institute will upgrade its nurse ... Company Fund, according to Nick Karmanos, vice,president of ... ), "As Lead Sponsor for our 26th ...
... guidelines say differences between nonprofit, for-profit banks should be ... Doctors should tell pregnant patients considering umbilical cord blood ... private cord blood banks, new guidelines state. , The ... revised Committee Opinion in the February issue of ...
Cached Medicine News:Health News:West Hollywood: AHF Hosts Grand Opening of HIV/AIDS Pharmacy that Benefits AIDS Patients Worldwide 2Health News:West Hollywood: AHF Hosts Grand Opening of HIV/AIDS Pharmacy that Benefits AIDS Patients Worldwide 3Health News:Medicare's Drug Program Enrollment Up, Costs Down 2Health News:Medicare's Drug Program Enrollment Up, Costs Down 3Health News:Drug-based on MGH discovery may significantly improve treatment of dangerous blood disorder 2Health News:Ford Motor Company Fund Continues Longtime Support to Cancer Care 2Health News:Docs Should Tell All About Cord Blood Banks 2
5x6mm Loop, 2 Irrigation Ports at 10, 2 O'Clock, 18 Gauge Thin Walled 1.2mm Shaft; overall length 40mm; stainless steel...
... long, thick-walled cannula which contains a coaxial ... Helical Loop Basket and a Tip Deflecting ... the outer cannula to carry these two ... right atrium. (Requires a Handle for Tip ...
... a non-invasive, virtually pain-free alternative to conventional ... selected indications. With Leksell Gamma Knife C ... positioning improves the ability to mould the ... This allows a more selective irradiation and ...
Clinac Platinum Plus accelerators offer all the high performance features of the EX series and come with the latest high-precision dose sculpting technology for advanced tumor control....
Medicine Products: